CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 24 enrolled
Drug / intervention
Furosemide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01440764
NCT01440764Phase 2Completed
CompareCT.gov

Aerosol Inhalation Treatment for Dyspnea

Beth Israel Deaconess Medical Center·interventional·Posted Sep 27, 2011·Updated Jun 14, 2017

In Brief

A Phase 2 clinical trial evaluating Furosemide and Saline for Healthy and Dyspnea. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The purpose of this protocol is to develop and test optimal delivery of aerosol furosemide, a treatment that has the potential to significantly improve symptom management and enhance the quality of care for patients with intractable dyspnea.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy, Dyspnea
CountriesUnited States
CollaboratorsNational Institute of Nursing Research (NINR)

Timeline

Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 27, 2011
Enrollment StartSep 1, 2011
Primary CompletionApr 1, 2016
Study CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 14.8 years ago

Interventions

Furosemidedrug

Salinedrug